|
This website has been developed to provide information
and resources on continuous dopaminergic stimulation with
co-careldopa infusion.
Co-careldopa is a combination of levodopa and carbidopa.
Its brand name is Duodopa and it is indicated for the treatment
of advanced levodopa-responsive Parkinsons disease
with severe motor fluctuations and hyper-/dyskinesia when
available combinations of Parkinson medicinal products have
not given satisfactory results.
A positive test of the clinical response to Duodopa administered
via a temporary nasoduodenal tube is required before a permanent
tube is inserted.
If
you are a member of the general public, perhaps a patient
or carer, please use the menu on the left hand side of the
page to access information.
If you are a UK healthcare professional, please click
here to register and explore the healthcare professional's
site.
If you are already a registered user, please log-on to
the healthcare professional site using the HCP Site Login
box on the left hand side of the page.
The information provided on Solvay Healthcare Limiteds
website is subject to the following
Legal and Copyright information.
|